Mifepristone or inhibition of 11β-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Δ(9)-tetrahydrocannabinol in mice
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The cannabinoid system is a regulator of neurotransmission and is linked with hormonal control. We have found in experimental mouse studies that the progesterone receptor inhibitor mifepristone (RU38486, 80 mg/kg i.p.) or the 11beta-hydroxylase inhibitor metyrapone (100 mg/kg i.p.) when administered in combination with cannabinoids potentiates the transient-sedating cannabinoid receptor-1 effects of a high-dose Delta(9)-tetrahydrocannabinol (25 mg/kg i.p.), causing severe prolonged sedation associated with hypomotility, catalepsy and hypothermia. This observation has implications for human subjects taking these drugs and related compounds particularly because of the ubiquitous use of cannabis and the high potential for mifepristone and related compounds to become available on the 'black-market' as abortifacients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Cannabinoids control spasticity and tremor in a multiple sclerosis model
Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Huffman, J. W., & Layward, L. (2000) · Nature · doi:10.1038/35003583 · Cited by 532
Self-citationDrinking, smoking, and illicit drug use among 15 and 16 year olds in the United Kingdom
Miller, P. M., & Plant, M. (1996) · BMJ · doi:10.1136/bmj.313.7054.394 · Cited by 297
Function of Cannabinoid Receptors in the Neuroendocrine Regulation of Hormone Secretion
Murphy, L. L., Muñoz, R. M., Adrian, B. A., & Villanúa, M. A. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0224 · Cited by 176
Tarcic, N., Ovadia, H., Weiss, D. W., & Weidenfeld, J. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00186-0 · Cited by 144
Suppression of experimetal autoimmune encephalomyelitis by cannabinoids
Wirguin, I., Mechoulam, R., Breuer, A., Schezen, E., Weidenfeld, J., & Brenner, T. (1994) · Immunopharmacology · doi:10.1016/0162-3109(94)90056-6 · Cited by 130
Brooks, J. W., Pryce, G., Bisogno, T., Jaggar, S., Hankey, D. J. R., Brown, P., Bridges, D., Ledent, C. A., Bifulco, M., Rice, A. S. C., et al. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01369-9 · Cited by 85
Self-citationRawls, S. M., Cowan, A., Tallarida, R. J., Geller, E. B., & Adler, M. W. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037473 · Cited by 41
Effects of marijuana on neuroendocrine hormones in human males and females.
Mendelson, J. H., & Mello, N. K. (1984) · PubMed · Cited by 32
Research works printed but not linked: 1
- Baker, 2001, Cannabinoid-mediated treatment of autoimmune disease of the CNS and eye, J. Neuroimmunol., 118, 55
Cited by
Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action
Ayoub, S. S. (2021) · Temperature · doi:10.1080/23328940.2021.1886392 · Cited by 223
Muthian, S., Rademacher, D. J., Roelke, C. T., Gross, G. J., & Hillard, C. J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.044 · Cited by 148
Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus
Hill, M. N., Carrier, E. J., Ho, W. ‐. V., Shi, L., Patel, S., Gorzalka, B. B., & Hillard, C. J. (2008) · Hippocampus · doi:10.1002/hipo.20386 · Cited by 96
“…of adrenal steroid actions through adrenalectomy or pharmacological blockade of the glucocorticoid receptor potentiates the physiological, endocrine, and behavioral effects of administration of cannabinoid CB1 receptor agonists (Gordon et al., 1978; Jackson and Murphy, 1997; Pryce et al., 2003).”
Croxford, J. L., Pryce, G., Jackson, S. J., Ledent, C. A., Giovannoni, G., Pertwee, R. G., Yamamura, T., & Baker, D. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.10.024 · Cited by 100
Self-citationde Bitencourt, R. M., Pamplona, F. A., & Takahashi, R. N. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.039 · Cited by 90
“…blocked of glucocorticoid receptors results in a sensitization of behavioral and physiological responses to cannabinoids (Gordon et al., 1978; Jackson andMurphy, 1997; Pryce et al., 2003), suggesting that cannabinoid receptors may be negatively regulated by glucocorticoids in a tonic fashion.”
Metadata
- Authors
- Pryce, G., Giovannoni, G., & Baker, D.
- Affiliations
- National Hospital for Neurology and Neurosurgery (GB)
- Corresponding author
- Giovannoni, Gavin
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 341
- Issue
- 2
- Pages
- 164-166
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W1986048570
- Cited by
- 22
- References
- 8
- Citations by year
- 2023: 1 · 2021: 3 · 2017: 1 · 2015: 1 · 2014: 1 · 2012: 3
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Multiple Sclerosis Society
- National Institute on Drug Abuse
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- mifepristone, metyrapone, 11β-hydroxylase inhibition, progesterone receptor, CB1 receptor, delta-9-tetrahydrocannabinol, drug potentiation, sedation, catalepsy, hypothermia, hypomotility, cannabis
- MeSH terms
- Animals, Body Temperature Regulation, Drug Synergism, Enzyme Inhibitors, Hormone Antagonists, Male, Metyrapone, Receptors, Drug, Dronabinol, Time Factors, Mifepristone, Procedural Sedation, Analgesics, Non-Narcotic, Receptors, Cannabinoid, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mifepristone or inhibition of 11β-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Δ(9)-tetrahydrocannabinol in mice. https://app.cochat.ai/papers/10.1016/s0304-3940(03)00159-9
- The paper
- Pryce, G., Giovannoni, G., & Baker, D. (2003). Mifepristone or inhibition of 11β-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Δ(9)-tetrahydrocannabinol in mice. Neuroscience Letters. https://doi.org/10.1016/s0304-3940(03)00159-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.